These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

206 related items for PubMed ID: 25082473

  • 21. Clinicopathologic characteristics of patients with resected multifocal intraductal papillary mucinous neoplasm of the pancreas.
    Fritz S, Schirren M, Klauss M, Bergmann F, Hackert T, Hartwig W, Strobel O, Grenacher L, Büchler MW, Werner J.
    Surgery; 2012 Sep; 152(3 Suppl 1):S74-80. PubMed ID: 22770954
    [Abstract] [Full Text] [Related]

  • 22. The distance of tumor spread in the main pancreatic duct of an intraductal papillary-mucinous neoplasm: where to resect and how to predict it.
    Okada K, Imaizumi T, Hirabayashi K, Matsuyama M, Yazawa N, Dowaki S, Tobita K, Ohtani Y, Kawaguchi Y, Tanaka M, Inokuchi S, Makuuchi H.
    J Hepatobiliary Pancreat Sci; 2010 Jul; 17(4):516-22. PubMed ID: 20714841
    [Abstract] [Full Text] [Related]

  • 23. Intraductal papillary mucinous neoplasms: predictors of malignant and invasive pathology.
    Schmidt CM, White PB, Waters JA, Yiannoutsos CT, Cummings OW, Baker M, Howard TJ, Zyromski NJ, Nakeeb A, DeWitt JM, Akisik FM, Sherman S, Pitt HA, Lillemoe KD.
    Ann Surg; 2007 Oct; 246(4):644-51; discussion 651-4. PubMed ID: 17893501
    [Abstract] [Full Text] [Related]

  • 24. Clinical implication of serum carcinoembryonic antigen and carbohydrate antigen 19-9 for the prediction of malignancy in intraductal papillary mucinous neoplasm of pancreas.
    Kim JR, Jang JY, Kang MJ, Park T, Lee SY, Jung W, Chang J, Shin Y, Han Y, Kim SW.
    J Hepatobiliary Pancreat Sci; 2015 Sep; 22(9):699-707. PubMed ID: 26178866
    [Abstract] [Full Text] [Related]

  • 25. Management of intraductal papillary-mucinous neoplasm of the pancreas: treatment strategy based on morphologic classification.
    Serikawa M, Sasaki T, Fujimoto Y, Kuwahara K, Chayama K.
    J Clin Gastroenterol; 2006 Oct; 40(9):856-62. PubMed ID: 17016145
    [Abstract] [Full Text] [Related]

  • 26. Intraductal papillary mucinous neoplasm (IPMN) with high-grade dysplasia is a risk factor for the subsequent development of pancreatic ductal adenocarcinoma.
    Rezaee N, Barbon C, Zaki A, He J, Salman B, Hruban RH, Cameron JL, Herman JM, Ahuja N, Lennon AM, Weiss MJ, Wood LD, Wolfgang CL.
    HPB (Oxford); 2016 Mar; 18(3):236-46. PubMed ID: 27017163
    [Abstract] [Full Text] [Related]

  • 27. Invasive intraductal papillary-mucinous neoplasm of the pancreas: comparison with pancreatic ductal adenocarcinoma.
    Murakami Y, Uemura K, Sudo T, Hayashidani Y, Hashimoto Y, Nakashima A, Sueda T.
    J Surg Oncol; 2009 Jul 01; 100(1):13-8. PubMed ID: 19384908
    [Abstract] [Full Text] [Related]

  • 28. Diffusion-weighted imaging in characterization of cystic pancreatic lesions.
    Sandrasegaran K, Akisik FM, Patel AA, Rydberg M, Cramer HM, Agaram NP, Schmidt CM.
    Clin Radiol; 2011 Sep 01; 66(9):808-14. PubMed ID: 21601184
    [Abstract] [Full Text] [Related]

  • 29. Histopathologic findings of multifocal pancreatic intraductal papillary mucinous neoplasms on CT.
    Raman SP, Kawamoto S, Blackford A, Hruban RH, Lennon AM, Wolfgang CL, Rezaee N, Edil B, Fishman EK.
    AJR Am J Roentgenol; 2013 Mar 01; 200(3):563-9. PubMed ID: 23436845
    [Abstract] [Full Text] [Related]

  • 30. Preoperative histological subtype classification of intraductal papillary mucinous neoplasms (IPMN) by pancreatic juice cytology with MUC stain.
    Hara T, Ikebe D, Odaka A, Sudo K, Nakamura K, Yamamoto H, Itami M, Hirata T, Kashimura J, Yamaguchi T.
    Ann Surg; 2013 Jun 01; 257(6):1103-11. PubMed ID: 23364699
    [Abstract] [Full Text] [Related]

  • 31. Value of 3-T MR imaging in intraductal papillary mucinous neoplasm with a concomitant invasive carcinoma.
    Sotozono H, Kanki A, Yasokawa K, Yamamoto A, Sanai H, Moriya K, Tamada T.
    Eur Radiol; 2022 Dec 01; 32(12):8276-8284. PubMed ID: 35665843
    [Abstract] [Full Text] [Related]

  • 32. Determination of malignant and invasive predictors in branch duct type intraductal papillary mucinous neoplasms of the pancreas: a suggested scoring formula.
    Hwang DW, Jang JY, Lim CS, Lee SE, Yoon YS, Ahn YJ, Han HS, Kim SW, Kim SG, Yun YK, Han SS, Park SJ, Lim TJ, Kang KJ, Sim MS, Choi SH, Heo JS, Choi DW, Hur KY, Lee DS, Yun SS, Kim HJ, Cho CK, Kim HJ, Yu HC, Cho BH, Song IS.
    J Korean Med Sci; 2011 Jun 01; 26(6):740-6. PubMed ID: 21655058
    [Abstract] [Full Text] [Related]

  • 33. Inferior head resection of the pancreas for intraductal papillary mucinous neoplasms.
    Nakagohri T, Kinoshita T, Konishi M, Takahashi S, Gotohda N, Kobayashi S, Kojima M, Miyauchi H, Asano T.
    J Hepatobiliary Pancreat Sci; 2010 Nov 01; 17(6):798-802. PubMed ID: 19727540
    [Abstract] [Full Text] [Related]

  • 34. Magnetic resonance imaging short protocols for intraductal papillary mucinous neoplasm (IPMN) surveillance: The time has come.
    D'Onofrio M, Geraci L, De Robertis RL, Cardobi N, Balduzzi A, Tomaiuolo L, Bardhi E, Faccioli N, Aluffi G, Marchegiani G, Salvia R.
    Dig Liver Dis; 2024 Sep 01; 56(9):1551-1556. PubMed ID: 38614923
    [Abstract] [Full Text] [Related]

  • 35. Intraductal papillary mucinous neoplasm.
    Shi C, Hruban RH.
    Hum Pathol; 2012 Jan 01; 43(1):1-16. PubMed ID: 21777948
    [Abstract] [Full Text] [Related]

  • 36. Clinical implication of morphological subtypes in management of intraductal papillary mucinous neoplasm.
    Yamada S, Fujii T, Shimoyama Y, Kanda M, Nakayama G, Sugimoto H, Koike M, Nomoto S, Fujiwara M, Nakao A, Kodera Y.
    Ann Surg Oncol; 2014 Jul 01; 21(7):2444-52. PubMed ID: 24562937
    [Abstract] [Full Text] [Related]

  • 37. Evaluation of SOX9 expression in pancreatic ductal adenocarcinoma and intraductal papillary mucinous neoplasm.
    Tanaka T, Kuroki T, Adachi T, Ono S, Hirabaru M, Soyama A, Kitasato A, Takatsuki M, Hayashi T, Eguchi S.
    Pancreas; 2013 Apr 01; 42(3):488-93. PubMed ID: 23146920
    [Abstract] [Full Text] [Related]

  • 38. Intraductal papillary mucinous neoplasms of the pancreas--predictors of malignancy.
    Fan F, Lai EC, Xie F, Yang JM, Xu F, Kan T, Shen RX, Yang XY, Lau Wan Y, Wu MC.
    Hepatogastroenterology; 2010 Apr 01; 57(99-100):635-9. PubMed ID: 20698241
    [Abstract] [Full Text] [Related]

  • 39. Pancreatic main-duct involvement in branch-duct IPMNs: an underestimated risk.
    Fritz S, Klauss M, Bergmann F, Strobel O, Schneider L, Werner J, Hackert T, Büchler MW.
    Ann Surg; 2014 Nov 01; 260(5):848-55; discussion 855-6. PubMed ID: 25379856
    [Abstract] [Full Text] [Related]

  • 40. Pancreatic ductal adenocarcinoma derived from IPMN and pancreatic ductal adenocarcinoma concomitant with IPMN.
    Yamaguchi K, Kanemitsu S, Hatori T, Maguchi H, Shimizu Y, Tada M, Nakagohri T, Hanada K, Osanai M, Noda Y, Nakaizumi A, Furukawa T, Ban S, Nobukawa B, Kato Y, Tanaka M.
    Pancreas; 2011 May 01; 40(4):571-80. PubMed ID: 21499212
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 11.